参考文献/References:
[1]Enzo B,Stefan K,Johann W,et al.Prevalence of insulin resistance in metabolic disorders:the Bruneck Study[J].Diabetes,1998,47(10):1643-1649.
[2]Amini M,Janghorbani M.Diabetes and impaired glucose regulation in first-degree relatives of patients with type 2 diabetes in isfahan,iran:prevalence and risk factors[J].Rev Diabet Stud,2007,4(3):169-176.
[3]裴晓艳,金国玺,毕娅欣,等.血清骨钙素、白细胞介素-18在不同糖耐量人群的变化及其与2型糖尿病颈动脉粥样硬化的关系[J].中国循环杂志,2017,32(7):684-688.
[4]余显霞,曹蕾,熊雪松.阿司匹林肠溶片联合阿托伐他汀钙片对糖尿病动脉粥样硬化的干预治疗研究[J].川北医学院学报,2017,32(3):358-360.
[5]吴利,朱红,曹长春,等.2型糖尿病患者颈动脉及下肢动脉硬化相关危险因素分析[J].当代医学,2018,24(6):12-15.
[6]Heinrich G,Ghadieh HE,Ghanem SS,et al.Loss of Hepatic CEACAM1:A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease[J].Front Endocrinol (Lausanne),2017(8):8.
[7]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-67.
[8]中国健康体检人群颈动脉超声检查规范[J].中华健康管理学杂志,2015,(4):254-260.
[9]Xu Y,Wang L,He J,et al.Prevalence and control of diabetes in Chinese adults[J].JAMA,2013,310(9):948-959.
[10]Friedrich SK,Lang PA,Friebus-Kardash J,et al.Mechanisms of lymphatic system-specific viral replication and its potential role in autoimmune disease[J].Clinical and Experimental Immunology,2019,195(1):64-73.
[11]Nagaishi T,Iijima H,Nakajima A,et al. Role of CEACAM1 as a regulator of T cells[J].Ann N Y Acad Sci,2006(1072):155-175.
[12]Weiner GM,Ducruet AF.CEACAM1:a novel adhesion molecule that regulates the secretion of matrix metalloproteinase-9 in neutrophils and protects the blood-brain barrier after ischemic stroke[J].Neurosurgery,2014,75(4):N21-N22.
[13]Wang Y,Chen Y,Yan Y,et al.Loss of ceacam1,a tumor-associated factor,attenuates post-infarction cardiac remodeling by inhibiting apoptosis[J].Scientific Reports,2016(6):21972.
[14]DeAngelis AM,Heinrich G,Dai T,et al.Carcinoembryonic antigen-related cell adhesion molecule 1:A link between insulin and lipid metabolism[J].Diabetes,2008,57(9):2296-2303.
[15]张凤丽,何立娟,崔清华,等.血清胎球蛋白A水平对糖耐量减低的预测价值[J].疑难病杂志,2018,17(5):464-467.